English
简体中文
Total: £ 56.28
Published Date: 2025-10-31 | Pages: 156 | Tables: 165 | More & Other
The global Pharmaceutical Polymer Vials market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Injectable Drugs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Polymer Vials leading manufacturers including Bormioli Pharma, Nipro, Piramal Glass, Corning, DWK Life Sciences, APG, Gerresheimer, SCHOTT, Berry Global, West Pharmaceutical Services, etc., dominate supply; the top five capture approximately % of global revenue, with Bormioli Pharma leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Polymer Vials market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Bormioli Pharma
Nipro
Piramal Glass
Corning
DWK Life Sciences
APG
Gerresheimer
SCHOTT
Berry Global
West Pharmaceutical Services
Origin Pharma Packaging
SGD Pharma
Pacific Vial
Stevanato
Segment by Type
Nipple Bottle
Double Chambered Bottle
Threaded Bottle
Other
Segment by Application
Injectable Drugs
Oral Liquid
Biological Agent
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Pharmaceutical Polymer Vials study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Pharmaceutical Polymer Vials: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Polymer Vials Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nipple Bottle
1.2.3 Double Chambered Bottle
1.2.4 Threaded Bottle
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Polymer Vials Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable Drugs
1.3.3 Oral Liquid
1.3.4 Biological Agent
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Polymer Vials Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Polymer Vials Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Polymer Vials Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Polymer Vials Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pharmaceutical Polymer Vials Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pharmaceutical Polymer Vials Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Nipple Bottle Market Size by Manufacturers
3.5.2 Double Chambered Bottle Market Size by Manufacturers
3.5.3 Threaded Bottle Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Pharmaceutical Polymer Vials Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Polymer Vials Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Polymer Vials Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Polymer Vials Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pharmaceutical Polymer Vials Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
6.4 North America Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Polymer Vials Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
7.4 Europe Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Polymer Vials Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pharmaceutical Polymer Vials Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Polymer Vials Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Polymer Vials Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Polymer Vials Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Polymer Vials Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bormioli Pharma
11.1.1 Bormioli Pharma Corporation Information
11.1.2 Bormioli Pharma Business Overview
11.1.3 Bormioli Pharma Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.1.4 Bormioli Pharma Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Product in 2024
11.1.6 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Application in 2024
11.1.7 Bormioli Pharma Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.1.8 Bormioli Pharma Pharmaceutical Polymer Vials SWOT Analysis
11.1.9 Bormioli Pharma Recent Developments
11.2 Nipro
11.2.1 Nipro Corporation Information
11.2.2 Nipro Business Overview
11.2.3 Nipro Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.2.4 Nipro Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Nipro Pharmaceutical Polymer Vials Sales by Product in 2024
11.2.6 Nipro Pharmaceutical Polymer Vials Sales by Application in 2024
11.2.7 Nipro Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.2.8 Nipro Pharmaceutical Polymer Vials SWOT Analysis
11.2.9 Nipro Recent Developments
11.3 Piramal Glass
11.3.1 Piramal Glass Corporation Information
11.3.2 Piramal Glass Business Overview
11.3.3 Piramal Glass Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.3.4 Piramal Glass Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Piramal Glass Pharmaceutical Polymer Vials Sales by Product in 2024
11.3.6 Piramal Glass Pharmaceutical Polymer Vials Sales by Application in 2024
11.3.7 Piramal Glass Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.3.8 Piramal Glass Pharmaceutical Polymer Vials SWOT Analysis
11.3.9 Piramal Glass Recent Developments
11.4 Corning
11.4.1 Corning Corporation Information
11.4.2 Corning Business Overview
11.4.3 Corning Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.4.4 Corning Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Corning Pharmaceutical Polymer Vials Sales by Product in 2024
11.4.6 Corning Pharmaceutical Polymer Vials Sales by Application in 2024
11.4.7 Corning Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.4.8 Corning Pharmaceutical Polymer Vials SWOT Analysis
11.4.9 Corning Recent Developments
11.5 DWK Life Sciences
11.5.1 DWK Life Sciences Corporation Information
11.5.2 DWK Life Sciences Business Overview
11.5.3 DWK Life Sciences Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.5.4 DWK Life Sciences Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Product in 2024
11.5.6 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Application in 2024
11.5.7 DWK Life Sciences Pharmaceutical Polymer Vials Sales by Geographic Area in 2024
11.5.8 DWK Life Sciences Pharmaceutical Polymer Vials SWOT Analysis
11.5.9 DWK Life Sciences Recent Developments
11.6 APG
11.6.1 APG Corporation Information
11.6.2 APG Business Overview
11.6.3 APG Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.6.4 APG Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 APG Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Business Overview
11.7.3 Gerresheimer Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.7.4 Gerresheimer Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Gerresheimer Recent Developments
11.8 SCHOTT
11.8.1 SCHOTT Corporation Information
11.8.2 SCHOTT Business Overview
11.8.3 SCHOTT Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.8.4 SCHOTT Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SCHOTT Recent Developments
11.9 Berry Global
11.9.1 Berry Global Corporation Information
11.9.2 Berry Global Business Overview
11.9.3 Berry Global Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.9.4 Berry Global Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Berry Global Recent Developments
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Corporation Information
11.10.2 West Pharmaceutical Services Business Overview
11.10.3 West Pharmaceutical Services Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.10.4 West Pharmaceutical Services Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 West Pharmaceutical Services Recent Developments
11.11 Origin Pharma Packaging
11.11.1 Origin Pharma Packaging Corporation Information
11.11.2 Origin Pharma Packaging Business Overview
11.11.3 Origin Pharma Packaging Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.11.4 Origin Pharma Packaging Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Origin Pharma Packaging Recent Developments
11.12 SGD Pharma
11.12.1 SGD Pharma Corporation Information
11.12.2 SGD Pharma Business Overview
11.12.3 SGD Pharma Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.12.4 SGD Pharma Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 SGD Pharma Recent Developments
11.13 Pacific Vial
11.13.1 Pacific Vial Corporation Information
11.13.2 Pacific Vial Business Overview
11.13.3 Pacific Vial Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.13.4 Pacific Vial Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Pacific Vial Recent Developments
11.14 Stevanato
11.14.1 Stevanato Corporation Information
11.14.2 Stevanato Business Overview
11.14.3 Stevanato Pharmaceutical Polymer Vials Product Models, Descriptions and Specifications
11.14.4 Stevanato Pharmaceutical Polymer Vials Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Stevanato Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pharmaceutical Polymer Vials Industry Chain
12.2 Pharmaceutical Polymer Vials Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pharmaceutical Polymer Vials Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pharmaceutical Polymer Vials Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Polymer Vials Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Polymer Vials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Polymer Vials Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Polymer Vials Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Polymer Vials Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Pharmaceutical Polymer Vials Sales by Region (2020-2025) & (K Units)
Table 8. Global Pharmaceutical Polymer Vials Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Polymer Vials Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Pharmaceutical Polymer Vials Sales Share by Manufacturers (2020-2025)
Table 12. Global Pharmaceutical Polymer Vials Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Pharmaceutical Polymer Vials Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Pharmaceutical Polymer Vials by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Polymer Vials as of 2024)
Table 16. Global Pharmaceutical Polymer Vials Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Pharmaceutical Polymer Vials Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Pharmaceutical Polymer Vials Manufacturing Base and Headquarters
Table 19. Global Pharmaceutical Polymer Vials Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Pharmaceutical Polymer Vials Sales by Type (2020-2025) & (K Units)
Table 23. Global Pharmaceutical Polymer Vials Sales by Type (2026-2031) & (K Units)
Table 24. Global Pharmaceutical Polymer Vials Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical Polymer Vials Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Pharmaceutical Polymer Vials ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Pharmaceutical Polymer Vials Sales by Application (2020-2025) & (K Units)
Table 29. Global Pharmaceutical Polymer Vials Sales by Application (2026-2031) & (K Units)
Table 30. Pharmaceutical Polymer Vials High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Pharmaceutical Polymer Vials Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Pharmaceutical Polymer Vials Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Pharmaceutical Polymer Vials ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
Table 37. North America Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
Table 40. Europe Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Pharmaceutical Polymer Vials Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Pharmaceutical Polymer Vials Growth Accelerators and Market Barriers
Table 45. Southeast Asia Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Pharmaceutical Polymer Vials Investment Opportunities and Key Challenges
Table 47. Central and South America Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Pharmaceutical Polymer Vials Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Pharmaceutical Polymer Vials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bormioli Pharma Corporation Information
Table 51. Bormioli Pharma Description and Major Businesses
Table 52. Bormioli Pharma Product Models, Descriptions and Specifications
Table 53. Bormioli Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bormioli Pharma Sales Value Proportion by Product in 2024
Table 55. Bormioli Pharma Sales Value Proportion by Application in 2024
Table 56. Bormioli Pharma Sales Value Proportion by Geographic Area in 2024
Table 57. Bormioli Pharma Pharmaceutical Polymer Vials SWOT Analysis
Table 58. Bormioli Pharma Recent Developments
Table 59. Nipro Corporation Information
Table 60. Nipro Description and Major Businesses
Table 61. Nipro Product Models, Descriptions and Specifications
Table 62. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Nipro Sales Value Proportion by Product in 2024
Table 64. Nipro Sales Value Proportion by Application in 2024
Table 65. Nipro Sales Value Proportion by Geographic Area in 2024
Table 66. Nipro Pharmaceutical Polymer Vials SWOT Analysis
Table 67. Nipro Recent Developments
Table 68. Piramal Glass Corporation Information
Table 69. Piramal Glass Description and Major Businesses
Table 70. Piramal Glass Product Models, Descriptions and Specifications
Table 71. Piramal Glass Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Piramal Glass Sales Value Proportion by Product in 2024
Table 73. Piramal Glass Sales Value Proportion by Application in 2024
Table 74. Piramal Glass Sales Value Proportion by Geographic Area in 2024
Table 75. Piramal Glass Pharmaceutical Polymer Vials SWOT Analysis
Table 76. Piramal Glass Recent Developments
Table 77. Corning Corporation Information
Table 78. Corning Description and Major Businesses
Table 79. Corning Product Models, Descriptions and Specifications
Table 80. Corning Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Corning Sales Value Proportion by Product in 2024
Table 82. Corning Sales Value Proportion by Application in 2024
Table 83. Corning Sales Value Proportion by Geographic Area in 2024
Table 84. Corning Pharmaceutical Polymer Vials SWOT Analysis
Table 85. Corning Recent Developments
Table 86. DWK Life Sciences Corporation Information
Table 87. DWK Life Sciences Description and Major Businesses
Table 88. DWK Life Sciences Product Models, Descriptions and Specifications
Table 89. DWK Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. DWK Life Sciences Sales Value Proportion by Product in 2024
Table 91. DWK Life Sciences Sales Value Proportion by Application in 2024
Table 92. DWK Life Sciences Sales Value Proportion by Geographic Area in 2024
Table 93. DWK Life Sciences Pharmaceutical Polymer Vials SWOT Analysis
Table 94. DWK Life Sciences Recent Developments
Table 95. APG Corporation Information
Table 96. APG Description and Major Businesses
Table 97. APG Product Models, Descriptions and Specifications
Table 98. APG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. APG Recent Developments
Table 100. Gerresheimer Corporation Information
Table 101. Gerresheimer Description and Major Businesses
Table 102. Gerresheimer Product Models, Descriptions and Specifications
Table 103. Gerresheimer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Gerresheimer Recent Developments
Table 105. SCHOTT Corporation Information
Table 106. SCHOTT Description and Major Businesses
Table 107. SCHOTT Product Models, Descriptions and Specifications
Table 108. SCHOTT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. SCHOTT Recent Developments
Table 110. Berry Global Corporation Information
Table 111. Berry Global Description and Major Businesses
Table 112. Berry Global Product Models, Descriptions and Specifications
Table 113. Berry Global Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Berry Global Recent Developments
Table 115. West Pharmaceutical Services Corporation Information
Table 116. West Pharmaceutical Services Description and Major Businesses
Table 117. West Pharmaceutical Services Product Models, Descriptions and Specifications
Table 118. West Pharmaceutical Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. West Pharmaceutical Services Recent Developments
Table 120. Origin Pharma Packaging Corporation Information
Table 121. Origin Pharma Packaging Description and Major Businesses
Table 122. Origin Pharma Packaging Product Models, Descriptions and Specifications
Table 123. Origin Pharma Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Origin Pharma Packaging Recent Developments
Table 125. SGD Pharma Corporation Information
Table 126. SGD Pharma Description and Major Businesses
Table 127. SGD Pharma Product Models, Descriptions and Specifications
Table 128. SGD Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. SGD Pharma Recent Developments
Table 130. Pacific Vial Corporation Information
Table 131. Pacific Vial Description and Major Businesses
Table 132. Pacific Vial Product Models, Descriptions and Specifications
Table 133. Pacific Vial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Pacific Vial Recent Developments
Table 135. Stevanato Corporation Information
Table 136. Stevanato Description and Major Businesses
Table 137. Stevanato Product Models, Descriptions and Specifications
Table 138. Stevanato Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Stevanato Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Polymer Vials Product Picture
Figure 2. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Nipple Bottle Product Picture
Figure 4. Double Chambered Bottle Product Picture
Figure 5. Threaded Bottle Product Picture
Figure 6. Other Product Picture
Figure 7. Global Pharmaceutical Polymer Vials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Injectable Drugs
Figure 9. Oral Liquid
Figure 10. Biological Agent
Figure 11. Other
Figure 12. Pharmaceutical Polymer Vials Report Years Considered
Figure 13. Global Pharmaceutical Polymer Vials Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 15. Global Pharmaceutical Polymer Vials Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Pharmaceutical Polymer Vials Revenue Market Share by Region (2020-2031)
Figure 17. Global Pharmaceutical Polymer Vials Sales (2020-2031) & (K Units)
Figure 18. Global Pharmaceutical Polymer Vials Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Pharmaceutical Polymer Vials Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Pharmaceutical Polymer Vials Sales Volume Market Share in 2024
Figure 21. Global Pharmaceutical Polymer Vials Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Nipple Bottle Revenue Market Share by Manufacturer in 2024
Figure 24. Double Chambered Bottle Revenue Market Share by Manufacturer in 2024
Figure 25. Threaded Bottle Revenue Market Share by Manufacturer in 2024
Figure 26. Other Revenue Market Share by Manufacturer in 2024
Figure 27. Global Pharmaceutical Polymer Vials Sales Market Share by Type (2020-2031)
Figure 28. Global Pharmaceutical Polymer Vials Revenue Market Share by Type (2020-2031)
Figure 29. Global Pharmaceutical Polymer Vials Sales Market Share by Application (2020-2031)
Figure 30. Global Pharmaceutical Polymer Vials Revenue Market Share by Application (2020-2031)
Figure 31. North America Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
Figure 32. North America Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
Figure 34. North America Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
Figure 44. Europe Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 49. France Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 64. India Pharmaceutical Polymer Vials Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Pharmaceutical Polymer Vials Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Pharmaceutical Polymer Vials Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Pharmaceutical Polymer Vials Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Pharmaceutical Polymer Vials Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Pharmaceutical Polymer Vials Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Pharmaceutical Polymer Vials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Pharmaceutical Polymer Vials Revenue (2020-2025) & (US$ Million)
Figure 85. Pharmaceutical Polymer Vials Industry Chain Mapping
Figure 86. Regional Pharmaceutical Polymer Vials Manufacturing Base Distribution (%)
Figure 87. Global Pharmaceutical Polymer Vials Production Market Share by Region (2020-2031)
Figure 88. Pharmaceutical Polymer Vials Production Process
Figure 89. Regional Pharmaceutical Polymer Vials Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
